BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 7819140)

  • 1. Involvement of 4F2 antigen expressed on the MHC-negative target cells in the recognition of murine CD3+CD4-CD8- alpha beta (V alpha 4/V beta 2) T cells.
    Kubota H; Sato M; Ogawa Y; Iwai K; Hattori M; Yoshida T; Minato N
    Int Immunol; 1994 Sep; 6(9):1323-31. PubMed ID: 7819140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin 7 induces preferential expansion of V beta 8.2+CD4-8- and V beta 8.2+CD4+8- murine thymocytes positively selected by class I molecules.
    Vicari A; de Moraes Mdo C; Gombert JM; Dy M; Penit C; Papiernik M; Herbelin A
    J Exp Med; 1994 Aug; 180(2):653-61. PubMed ID: 8046338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Programmed differentiation of murine thymocytes during fetal thymus organ culture.
    DeLuca D; Bluestone JA; Shultz LD; Sharrow SO; Tatsumi Y
    J Immunol Methods; 1995 Jan; 178(1):13-29. PubMed ID: 7829862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD3+CD16+NK1.1+B220+ large granular lymphocytes arise from both alpha-beta TCR+CD4-CD8- and gamma-delta TCR+CD4-CD8- cells.
    Koyasu S
    J Exp Med; 1994 Jun; 179(6):1957-72. PubMed ID: 8195719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T hybridoma alpha/beta gene transfected in a murine T cell hybridoma: role of CD4 molecule in vitro and in vivo--engraftment in SCID mice induces T cell maturation.
    Brunaud C; Carosella ED; Charpentier B
    Cell Immunol; 1992 Oct; 144(1):105-16. PubMed ID: 1356632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precommitment of CD4+CD8+ thymocytes to either CD4 or CD8 lineages.
    Crompton T; Lees RK; Pircher H; MacDonald HR
    Proc Natl Acad Sci U S A; 1993 Oct; 90(19):8982-6. PubMed ID: 8415641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4-CD8-C.B-17 SCID thymocytes enter the CD4+CD8+ stage in the presence of neonatally grafted T cells.
    Schneider MK; Grönvik KO
    Scand J Immunol; 1998 May; 47(5):466-74. PubMed ID: 9627131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of thymocyte development through CD3. I. Timepoint of ligation of CD3 epsilon determines clonal deletion or induction of developmental program.
    Levelt CN; Ehrfeld A; Eichmann K
    J Exp Med; 1993 Mar; 177(3):707-16. PubMed ID: 8382254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The kinetics of T cell antigen receptor expression by subgroups of CD4+8+ thymocytes: delineation of CD4+8+3(2+) thymocytes as post-selection intermediates leading to mature T cells.
    Shortman K; Vremec D; Egerton M
    J Exp Med; 1991 Feb; 173(2):323-32. PubMed ID: 1824855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD38 expression on mouse T cells: CD38 defines functionally distinct subsets of alpha beta TCR+CD4-CD8- thymocytes.
    Bean AG; Godfrey DI; Ferlin WG; Santos-Argumedo L; Parkhouse ME; Howard MC; Zlotnik A
    Int Immunol; 1995 Feb; 7(2):213-21. PubMed ID: 7734417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major histocompatibility complex class I related molecules control the development of CD4+8- and CD4-8- subsets of natural killer 1.1+ T cell receptor-alpha/beta+ cells in the liver of mice.
    Ohteki T; MacDonald HR
    J Exp Med; 1994 Aug; 180(2):699-704. PubMed ID: 8046344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxicity of fresh NK1.1+ T cell receptor alpha/beta+ thymocytes against a CD4+8+ thymocyte population associated with intact Fas antigen expression on the target.
    Arase H; Arase N; Kobayashi Y; Nishimura Y; Yonehara S; Onoé K
    J Exp Med; 1994 Aug; 180(2):423-32. PubMed ID: 7519236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans.
    Lantz O; Bendelac A
    J Exp Med; 1994 Sep; 180(3):1097-106. PubMed ID: 7520467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fc gamma RII/III and CD2 expression mark distinct subpopulations of immature CD4-CD8- murine thymocytes: in vivo developmental kinetics and T cell receptor beta chain rearrangement status.
    Rodewald HR; Awad K; Moingeon P; D'Adamio L; Rabinowitz D; Shinkai Y; Alt FW; Reinherz EL
    J Exp Med; 1993 Apr; 177(4):1079-92. PubMed ID: 8096236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unique properties of a cytotoxic CD4+CD8+ intraepithelial T-cell line established from the mouse intestinal epithelium.
    Sasahara T; Tamauchi H; Ikewaki N; Kubota K
    Microbiol Immunol; 1994; 38(3):191-9. PubMed ID: 8078424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MHC-specific graft-protective and delayed-type hypersensitivity (DTH) suppressive activity of a CD4+ CD8+, alpha beta T cell receptor (TCR) positive lymphoma isolated from a tolerant mouse.
    Jánossy T; Baranyi L; Knulst AC; Vizler C; Benner R; Végh P
    Immunobiology; 1993 Jun; 188(1-2):172-93. PubMed ID: 8406557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymic selection generates T cells expressing self-reactive TCRs in the absence of CD45.
    Trop S; Charron J; Arguin C; Lesage S; Hugo P
    J Immunol; 2000 Sep; 165(6):3073-9. PubMed ID: 10975818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell response to embryonal carcinoma F9 cells: induction and characterization of T cell receptor alpha beta+ double-negative cytotoxic T lymphocytes.
    Imada M; Fujimoto S
    Jpn J Cancer Res; 1993 Jan; 84(1):58-64. PubMed ID: 8095495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4-CD8- T cell receptor alpha beta T cells: generation of an in vitro major histocompatibility complex class I specific cytotoxic T lymphocyte response and allogeneic tumor rejection.
    Mieno M; Suto R; Obata Y; Udono H; Takahashi T; Shiku H; Nakayama E
    J Exp Med; 1991 Jul; 174(1):193-201. PubMed ID: 1905338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8 expression up to the double-positive CD3(low/intermediate) stage of thymic differentiation is sufficient for development of peripheral functional cytotoxic T lymphocytes.
    Zhang XL; Zhao S; Borenstein SH; Liu Y; Jayabalasingham B; Chamberlain JW
    J Exp Med; 2001 Sep; 194(5):685-93. PubMed ID: 11535636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.